DKK1 and breast cancer: In accordance with model predictions, low levels of Dkk1 (less than 10 ng/ml) do not significantly change the number of MS formed in ER+ BC cells from three primary samples primary BC, while doses of 10ng/ml or higher significantly reduce the number of MS formed by these cells, representing SC counts.